Maintenance Therapy of Levonorgestrel-releasing Intrauterine System (LNG-IUS) to Prevent the Recurrence of Symptomatic Endometriosis After Conservative Surgery

NCT01125488 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

80

Enrollment

OTHER_GOV

Sponsor class

Conditions

Endometriosis

Interventions

DEVICE: LNG-IUS
DRUG: GnRH agonist (triptorelin)

Sponsor

Taipei Veterans General Hospital, Taiwan